137 related articles for article (PubMed ID: 7476018)
1. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.
Schwarz M; Loewenstein-Lichtenstein Y; Glick D; Liao J; Norgaard-Pedersen B; Soreq H
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):101-10. PubMed ID: 7476018
[TBL] [Abstract][Full Text] [Related]
2. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
3. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase.
Neville LF; Gnatt A; Loewenstein Y; Soreq H
J Neurosci Res; 1990 Dec; 27(4):452-60. PubMed ID: 2079709
[TBL] [Abstract][Full Text] [Related]
4. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
[TBL] [Abstract][Full Text] [Related]
5. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.
Wong L; Radic Z; Brüggemann RJ; Hosea N; Berman HA; Taylor P
Biochemistry; 2000 May; 39(19):5750-7. PubMed ID: 10801325
[TBL] [Abstract][Full Text] [Related]
7. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
8. Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.
Masson P; Fortier PL; Albaret C; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):601-7. PubMed ID: 9359435
[TBL] [Abstract][Full Text] [Related]
9. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
Loewenstein-Lichtenstein Y; Glick D; Gluzman N; Sternfeld M; Zakut H; Soreq H
Mol Pharmacol; 1996 Dec; 50(6):1423-31. PubMed ID: 8967962
[TBL] [Abstract][Full Text] [Related]
10. Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.
Masson P; Bec N; Froment MT; Nachon F; Balny C; Lockridge O; Schopfer LM
Eur J Biochem; 2004 May; 271(10):1980-90. PubMed ID: 15128307
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic approaches and novel alternatives for organophosphate toxicity.
Katz FS; Pecic S; Schneider L; Zhu Z; Hastings-Robinson A; Luzac M; Macdonald J; Landry DW; Stojanovic MN
Toxicol Lett; 2018 Jul; 291():1-10. PubMed ID: 29614332
[TBL] [Abstract][Full Text] [Related]
12. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands.
Luo C; Ashani Y; Doctor BP
Mol Pharmacol; 1998 Apr; 53(4):718-26. PubMed ID: 9547363
[TBL] [Abstract][Full Text] [Related]
14. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations.
Katalinić M; Šinko G; Maček Hrvat N; Zorbaz T; Bosak A; Kovarik Z
Toxicology; 2018 Aug; 406-407():104-113. PubMed ID: 29772260
[TBL] [Abstract][Full Text] [Related]
15. Discovery of non-oxime reactivators using an in silico pharmacophore model of oxime reactivators of OP-inhibited acetylcholinesterase.
Bhattacharjee AK; Marek E; Le HT; Gordon RK
Eur J Med Chem; 2012 Mar; 49():229-38. PubMed ID: 22309910
[TBL] [Abstract][Full Text] [Related]
16. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
17. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
18. Probing the role of amino acids in oxime-mediated reactivation of nerve agent-inhibited human acetylcholinesterase.
Chambers C; Luo C; Tong M; Yang Y; Saxena A
Toxicol In Vitro; 2015 Mar; 29(2):408-14. PubMed ID: 25451328
[TBL] [Abstract][Full Text] [Related]
19. Effect of different oximes on rat and human cholinesterases inhibited by methamidophos: a comparative in vitro and in silico study.
Lugokenski TH; Gubert P; Bueno DC; Nogara PA; de Aquino Saraiva R; Barcelos RP; Carratu VS; Bresolin L; de Vargas Barbosa NB; Pereira ME; da Rocha JB; Soares FA
Basic Clin Pharmacol Toxicol; 2012 Dec; 111(6):362-70. PubMed ID: 22703537
[TBL] [Abstract][Full Text] [Related]
20. Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: acetylcholinesterase reactivation not at fault.
Polyzou A; Froment MT; Masson P; Belzunces LP
Toxicol Appl Pharmacol; 1998 Sep; 152(1):184-92. PubMed ID: 9772214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
